Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Edgewise Therapeutics Inc shares valued at $2,112,450 were sold by Russell Alan J on Nov 12 ’25. At $21.12 per share, Russell Alan J sold 100,000 shares. The insider’s holdings dropped to 23,400 shares worth approximately $0.48 million following the completion of this transaction.
Also, Fox Jonathan C purchased 10,700 shares, netting a total of over 199,403 in proceeds. Following the buying of shares at $18.64 each, the insider now holds 23,702 shares.
Before that, ALAN J RUSSELL had added 100,000 shares to its account. In a trade valued at $2,112,450, the Officer bought Edgewise Therapeutics Inc shares for $21.12 each.
As published in their initiating research note from Goldman on September 25, 2025, Edgewise Therapeutics Inc [EWTX] has been a Neutral and the price target has been revised to $20. Analysts at Raymond James started covering the stock with ‘”a Strong buy”‘ outlook in a report released in late July. As of June 30, 2025, H.C. Wainwright has initiated its “Buy” rating for EWTX. Earlier on April 30, 2025, Guggenheim initiated its rating. Their recommendation was “a Buy” for EWTX stock.
Analyzing EWTX Stock Performance
On last trading session, Edgewise Therapeutics Inc [NASDAQ: EWTX] plunged -3.54% to $20.42. The stock’s lowest price that day was $19.87, but it reached a high of $21.155 in the same session. During the last five days, there has been a surge of approximately 19.49%. Over the course of the year, Edgewise Therapeutics Inc shares have dropped approximately -42.20%. Shares of the company reached a 52-week high of $30.48 on 02/06/25 and a 52-week low of $10.60 on 04/07/25.
Support And Resistance Levels for Edgewise Therapeutics Inc (EWTX)
According to the 24-hour chart, there is a support level at 19.81, which, if violated, would cause prices to drop to 19.20. In the upper region, resistance lies at 21.09. The next price resistance is at 21.77. RSI (Relative Strength Index) is 67.39 on the 14-day chart, showing neutral technical sentiment.
Is Edgewise Therapeutics Inc subject to short interest?
Stocks of Edgewise Therapeutics Inc saw a sharp rise in short interest on 2025-10-31 jumping by 2.2 million shares to 9.51 million. Data from Yahoo Finance shows that the short interest on 2025-09-30 was 7.31 million shares. A jump of 23.14% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 11.24 of the overall float, the days-to-cover ratio (short ratio) jumped to 11.24.
Which companies own the most shares of Edgewise Therapeutics Inc (EWTX)?
In terms of Edgewise Therapeutics Inc share price expectations, FactSet research, analysts set an average price target of 20 in the next 12 months, down nearly -5.53% from the previous closing price of $21.17. Analysts anticipate Edgewise Therapeutics Inc stock to reach 20 by 2025, with the lowest price target being 20. In spite of this, 1 analysts ranked Edgewise Therapeutics Inc stock as Buy at the end of 2025. On April 02, 2025, Scotiabank assigned a price target of “a Sector perform” to the stock and downgraded coverage with a $14.
